Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer

Rucaparib is a potent small-molecule inhibitor of poly (ADP-ribose) polymerase (PARP) proteins (PARP-1, PARP-2 and PARP-3) that play an important role in repairing DNA damage and maintaining genomic stability. Tumors with mutations in BRCA1/2 or other homologous recombination deficiency (HRD) genes...

Descripción completa

Detalles Bibliográficos
Autores principales: Colombo, Ilaria, Lheureux, Stephanie, Oza, Amit Manulal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868608/
https://www.ncbi.nlm.nih.gov/pubmed/29606854
http://dx.doi.org/10.2147/DDDT.S130809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868608/
https://www.ncbi.nlm.nih.gov/pubmed/29606854
http://dx.doi.org/10.2147/DDDT.S130809

Ejemplares similares